Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 270

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease

Goris, An, Williams‐Gray, Caroline H., Clark, Graeme R., Foltynie, Thomas, Lewis, Simon J. G., Brown, Joanne, Ban, Maria, Spillantini, Maria G., Compston, Alastair, Burn, David J., Chinnery, Patrick F., Barker, Roger A., Sawcer, Stephen J.·2007·Annals of Neurology

Abstract

Objective: Parkinson's disease (PD) is a neurodegenerative condition that typically presents as a movement disorder but is known to be associated with variable degrees of cognitive impairment including dementia. We investigated the genetic basis of susceptibility to and cognitive heterogeneity of this disease. Methods: In 659 PD patients, 109 of which were followed up for 3.5 years from diagnosis, and 2,176 control subjects, we studied candidate genes involved in protein aggregation and inclusion body formation, the pathological hallmark of parkinsonism: microtubule‐associated protein tau (MAPT), glycogen synthase kinase‐3β (GSK3B), and α‐synuclein (SNCA). Results: We observed that cognitive decline and the development of PD dementia are strongly associated (p = 10−4) with the inversion polymorphism containing MAPT. We also found a novel synergistic interaction between the MAPT inversion polymorphism and the single nucleotide polymorphism rs356219 from the 3′ region of SNCA. In our data, carrying a risk genotype at either of these loci marginally increases the risk for development of PD, whereas carrying the combination of risk genotypes at both loci approximately doubles the risk for development of the disease (p = 3 × 10−6). Interpretation: Our data support the hypothesis that tau and α‐synuclein are involved in shared or converging pathways in the pathogenesis of PD, and suggest that the tau inversion influences the development of cognitive impairment and dementia in patients with idiopathic PD. These findings have potentially important implications for understanding the interface between tau and α‐synuclein pathways in neurodegenerative disorders and for unraveling the biological basis for cognitive impairment and dementia in PD. Ann Neurol 2007

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21192

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 270

Metadata

Authors
Goris, A., Williams‐Gray, C. H., Clark, G. R., Foltynie, T., Lewis, S. J. G., Brown, J., Ban, M., Spillantini, M. G., Compston, A., Burn, D. J., Chinnery, P. F., Barker, R. A., & Sawcer, S. J.
Venue
Annals of Neurology
Publisher
Wiley
Published
2007-08
Volume
62
Issue
2
Pages
145-153
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2064233040
Cited by
270
References
40
FWCI
10.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease. https://app.cochat.ai/papers/10.1002/ana.21192
The paper
Goris, A., Williams‐Gray, C. H., Clark, G. R., Foltynie, T., Lewis, S. J. G., Brown, J., Ban, M., Spillantini, M. G., Compston, A., Burn, D. J., Chinnery, P. F., Barker, R. A., & Sawcer, S. J. (2007). Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease. Annals of Neurology. https://doi.org/10.1002/ana.21192

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.